A carregar...
CDK7 inhibition is a novel therapeutic strategy against GBM both in vitro and in vivo
BACKGROUND: Glioblastoma multiforme (GBM) remains to be one of the top lethal cancer types for adult to date. Current GBM therapies suffer greatly from the highly heterogeneous and adaptable nature of GBM cells, indicating an urgent need of alternative therapeutic options. In this study, we focused...
Na minha lista:
| Publicado no: | Cancer Manag Res |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6245350/ https://ncbi.nlm.nih.gov/pubmed/30532595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S183696 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|